Bioinformatics analysis of BloodSpot indicated significantly elevated SRSF7 expression in AML with various fusion genes compared with hematopoietic stem cells from healthy donors (Fig. 1A). This evidence concerns the gene SRSF7 and acute myeloid leukemia.